Sélection de publications

  • Leserman, L.D., Weinstein, J.N., Blumenthal, R. and Terry, W.D. (1980). Receptor-mediated endocytosis of antibody opsonized liposomes by tumor cells. Proc. Natl. Acad Sci. USA. 77:4089-4093.
  • Leserman, L.D., Weinstein, J.N., Moore, J.J. and Terry, W.D. (1980) Specific interaction of myeloma tumor cells with hapten-bearing liposomes containing methotrexate and carboxyfluorescein. Cancer Res. 40: 4668-4674.
  • Leserman, L.D., Barbet, J., Weinstein, J.N. and Kourilsky, F. (1980). Targetting to cells of liposomes covalently coupled with monoclonal antibody or protein A. Nature. 289: 602-604.
  • Leserman. L.D., Machy, P. and Barbet, J. (1981). Cell specific drug transfer from liposomes bearing monoclonal antibodies. Nature. 292:226-228.
  • Machy, P., Barbet, J. and Leserman, L.D. (1982). Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody bearing fluorescent liposomes containing methotrexate. Proc Natl. Acad. Sci. USA. 79:4148-4152.
  • Truneh, A., Machy, P., Barbet, J., Mishal, Z., Lemonnier, F.A. and Leserman, L.D. (1983). Endocytosis of HLA and H-2 molecules on transformed murine cells measured by fluorescence dequenching of liposome-encapsulated carboxyfluorescein. EMBO J. 2: 2285-2291.
  • Machy, P. and Leserman, L.D. (1984). Elimination or rescue of cells in culture by specifically-targeted liposomes containing methotrexate or formyl-tetrahydrofolate. EMBO J. 3: 1971-1977.
  • Aragnol, D. and Leserman, L.D. (1986). Immune clearance of liposomes inhibited by an anti-Fc receptor antibody. Proc. Natl. Acad. Sci. USA. 83: 2699-2703.
  • Machy, P., Arnold, B, Aliño, S. and Leserman, L.D. (1986). Interferon sensitive and insensitive MHC variants of a murine thymoma differentially resistant to methotrexate-containing antibody-directed liposomes and immunotoxin. J. Immunol. 136: 3110-3115.
  • Schmitt-Verhulst, A.-M., Guimezanes, A., Boyer, C., Poenie, M., Tsien, R., Buferne, M., Hua, C. and Leserman, L. (1987). Pleitropic loss in activation pathways in a T cell receptor alpha chain deletion variant of a cytolytic T cell clone. Nature. 325: 628-631.
  • Liou, H.-C., Polla, B.S., Aragnol, D., Leserman, L.D., Griffith, I.J. and Glimcher, L.H. (1988). A tissue-specific DNAse I hypersensitive site in a class II A-alpha gene is under trans regulatory control. Proc. Natl. Acad. Sci. USA. 85: 2738-2742.
  • Leonetti, J.-P., Machy, P., Degols, G. Lebleu, B. and Leserman, L. (1990). Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication. Proc. Natl. Acad. Sci. USA. 87: 2448-2451.
  • Renneisen, K., Leserman, L., Matthes, E., Schröder, H.C. and Müller, W.E.G. (1990). Inhibition of expression of Human Immunodeficiency Virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. J. Biol. Chem. 265: 16337-16342.
  • Zelphati, O., Zon, G. and Leserman, L. (1993). Inhibition of HIV replication with antisense oligonucleotides encapsulated in immunoliposomes. Antisense Research and Development. 3: 323-338.
  • Serre, K., Machy, P., Grivel, J.-C., Jolly, G., Brun, N., Barbet, J. and Leserman, L. (1998). Dendritic cells present multivalent antigens targeted to various cell surface molecules as efficiently as antigen specific B cells via surface immunoglobulin. J. Immunol. 161: 6059-6067.
  • Zimmermann, V.S., Rovere, P., Trucy, J., Serre, K., Machy, P., Forquet, F., Leserman, L. and Davoust, J. (1999). Engagement of B cell receptors regulates the invariant chain dependent major histocompatibility complex class II presentation pathway. J. Immunol. 162: 2495-2502.
  • Forquet, F., Barois, N., Machy, P., Trucy, J., Leserman, L. and Davoust, J. (1999). Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules. J. Immunol. 162: 3408-3416.
  • Machy, P., Serre, K. and Leserman, L. (2000). Class I-restricted presentation of exogenous antigen acquired by Fcγ-receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 30: 848-857.
  • Machy, P., Serre, K., Baillet, M. and Leserman, L. (2002). Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains. J. Immunol. 168: 1172-1180.
  • Kissenpfennig, A., Henri, S., Dubois, B., Laplace-Builhé, C., Perrin, P., Romani, N., Tripp, C., Douillard, P., Leserman, L., Kaiserlian, D., Saeland, S., Davoust, J. and Malissen, B., Dynamics and function of Langerhans dendritic cells in vivo. Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005. 22: 643-654.
  • Serre, K., Giraudo, L., Siret, C., Leserman, L. and Machy, P., CD4 T cell help is required for primary CD8 T cell response to vesicular antigen delivered to dendritic cells in vivo. Eur. J. Immunol. 2006. 36: 1386-1397.
  • Henri, S., Siret, C., Machy, P., Kissenpfennig, A., Malissen, B. and Leserman, L. (2007). Mature dendritic cells from skin and skin-draining lymph nodes retain the ability to acquire and efficiently present targeted antigen. Eur. J. Immunol. 137. 1184-1193.
  • Shanker, A., Verdeil, G., Buferne, M., Inderberg-Suso, E.-M., Puthier, D., Joly, F., Nguyen, C., Leserman, L., Auphan-Anezin, N., and Schmitt-Verhulst, A.-M. (2007). CD8 T cell help for innate anti-tumor immunity. J. Immunol. 179:6651.
© 2019 Lee Leserman • lee@leserman.com